ASX - By Stock
|
ADO |
Re:
Ann: Application for quotation of securities - ADO
|
|
herro
|
72 |
25K |
45 |
08/02/22 |
08/02/22 |
ASX - By Stock
|
72
|
25K
|
45
|
|
ASX - By Stock
|
ADO |
Re:
Three rat tests approved
|
|
herro
|
105 |
34K |
26 |
15/10/21 |
15/10/21 |
ASX - By Stock
|
105
|
34K
|
26
|
|
ASX - By Stock
|
ADO |
Re:
EuGeni
|
|
herro
|
2.6K |
820K |
42 |
13/10/21 |
13/10/21 |
ASX - By Stock
|
2.6K
|
820K
|
42
|
|
ASX - By Stock
|
ADO |
Re:
EuGeni
|
|
herro
|
2.6K |
820K |
47 |
16/08/21 |
16/08/21 |
ASX - By Stock
|
2.6K
|
820K
|
47
|
|
ASX - By Stock
|
ADO |
Re:
COVID Testing
|
|
herro
|
121 |
38K |
123 |
01/06/21 |
01/06/21 |
ASX - By Stock
|
121
|
38K
|
123
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Novartis and Mesoblast Remestemcel-L Collaboration
|
|
herro
|
811 |
341K |
17 |
24/11/20 |
24/11/20 |
ASX - By Stock
|
811
|
341K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Novartis and Mesoblast Remestemcel-L Collaboration
|
|
herro
|
811 |
341K |
47 |
24/11/20 |
24/11/20 |
ASX - By Stock
|
811
|
341K
|
47
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
herro
|
18K |
7.1M |
47 |
19/11/20 |
19/11/20 |
ASX - By Stock
|
18K
|
7.1M
|
47
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
herro
|
18K |
7.1M |
49 |
13/11/20 |
13/11/20 |
ASX - By Stock
|
18K
|
7.1M
|
49
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
herro
|
18K |
7.1M |
50 |
12/11/20 |
12/11/20 |
ASX - By Stock
|
18K
|
7.1M
|
50
|
|
ASX - By Stock
|
MSB |
Re:
Ann: DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial
|
|
herro
|
392 |
161K |
87 |
11/11/20 |
11/11/20 |
ASX - By Stock
|
392
|
161K
|
87
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
herro
|
18K |
7.1M |
62 |
08/11/20 |
08/11/20 |
ASX - By Stock
|
18K
|
7.1M
|
62
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
herro
|
18K |
7.1M |
39 |
04/11/20 |
04/11/20 |
ASX - By Stock
|
18K
|
7.1M
|
39
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
herro
|
18K |
7.1M |
33 |
23/10/20 |
23/10/20 |
ASX - By Stock
|
18K
|
7.1M
|
33
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Phase 3 Trial in COVID-19 ARDS Surpasses 50% Enrollment
|
|
herro
|
445 |
197K |
16 |
14/10/20 |
14/10/20 |
ASX - By Stock
|
445
|
197K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
MSB to dispute FDA finding in Type A meeting
|
|
herro
|
1.0K |
510K |
70 |
12/10/20 |
12/10/20 |
ASX - By Stock
|
1.0K
|
510K
|
70
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
herro
|
18K |
7.1M |
75 |
06/10/20 |
06/10/20 |
ASX - By Stock
|
18K
|
7.1M
|
75
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
herro
|
635 |
281K |
49 |
01/10/20 |
01/10/20 |
ASX - By Stock
|
635
|
281K
|
49
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L
|
|
herro
|
854 |
435K |
68 |
26/09/20 |
26/09/20 |
ASX - By Stock
|
854
|
435K
|
68
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
herro
|
18K |
7.1M |
56 |
22/09/20 |
22/09/20 |
ASX - By Stock
|
18K
|
7.1M
|
56
|
|
ASX - By Stock
|
MSB |
Re:
Regenerative Medicine and Cell Therapies Virtual Event
|
|
herro
|
129 |
57K |
127 |
17/09/20 |
17/09/20 |
ASX - By Stock
|
129
|
57K
|
127
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
herro
|
18K |
7.1M |
49 |
12/09/20 |
12/09/20 |
ASX - By Stock
|
18K
|
7.1M
|
49
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
herro
|
18K |
7.1M |
49 |
11/09/20 |
11/09/20 |
ASX - By Stock
|
18K
|
7.1M
|
49
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Ethics Approval to Treat COVID-19 Patients in Australia
|
|
herro
|
320 |
131K |
18 |
03/09/20 |
03/09/20 |
ASX - By Stock
|
320
|
131K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
herro
|
18K |
7.1M |
9 |
02/09/20 |
02/09/20 |
ASX - By Stock
|
18K
|
7.1M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
herro
|
18K |
7.1M |
23 |
02/09/20 |
02/09/20 |
ASX - By Stock
|
18K
|
7.1M
|
23
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
herro
|
18K |
7.1M |
33 |
29/08/20 |
29/08/20 |
ASX - By Stock
|
18K
|
7.1M
|
33
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
herro
|
18K |
7.1M |
59 |
25/08/20 |
25/08/20 |
ASX - By Stock
|
18K
|
7.1M
|
59
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
herro
|
18K |
7.1M |
49 |
22/08/20 |
22/08/20 |
ASX - By Stock
|
18K
|
7.1M
|
49
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
herro
|
18K |
7.1M |
31 |
17/08/20 |
17/08/20 |
ASX - By Stock
|
18K
|
7.1M
|
31
|
|
ASX - By Stock
|
MSB |
Re:
FDA ODAC Meeting Material discussion analysis
|
|
herro
|
491 |
196K |
19 |
13/08/20 |
13/08/20 |
ASX - By Stock
|
491
|
196K
|
19
|
|
ASX - By Stock
|
MSB |
Re:
FDA ODAC Meeting Material discussion analysis
|
|
herro
|
491 |
196K |
64 |
13/08/20 |
13/08/20 |
ASX - By Stock
|
491
|
196K
|
64
|
|
ASX - By Stock
|
MSB |
Re:
FDA ODAC Meeting Material discussion analysis
|
|
herro
|
491 |
196K |
60 |
12/08/20 |
12/08/20 |
ASX - By Stock
|
491
|
196K
|
60
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L
|
|
herro
|
854 |
435K |
57 |
07/08/20 |
07/08/20 |
ASX - By Stock
|
854
|
435K
|
57
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
herro
|
18K |
7.1M |
5 |
06/08/20 |
06/08/20 |
ASX - By Stock
|
18K
|
7.1M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
herro
|
18K |
7.1M |
13 |
03/08/20 |
03/08/20 |
ASX - By Stock
|
18K
|
7.1M
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
herro
|
18K |
7.1M |
24 |
03/08/20 |
03/08/20 |
ASX - By Stock
|
18K
|
7.1M
|
24
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
herro
|
18K |
7.1M |
43 |
28/07/20 |
28/07/20 |
ASX - By Stock
|
18K
|
7.1M
|
43
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
herro
|
18K |
7.1M |
22 |
24/07/20 |
24/07/20 |
ASX - By Stock
|
18K
|
7.1M
|
22
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
herro
|
18K |
7.1M |
7 |
17/07/20 |
17/07/20 |
ASX - By Stock
|
18K
|
7.1M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
herro
|
18K |
7.1M |
24 |
09/07/20 |
09/07/20 |
ASX - By Stock
|
18K
|
7.1M
|
24
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
herro
|
18K |
7.1M |
7 |
30/06/20 |
30/06/20 |
ASX - By Stock
|
18K
|
7.1M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
herro
|
18K |
7.1M |
30 |
25/06/20 |
25/06/20 |
ASX - By Stock
|
18K
|
7.1M
|
30
|
|
ASX - By Stock
|
MSB |
Re:
BARDA, Vaccines not Treatment
|
|
herro
|
37 |
13K |
21 |
20/06/20 |
20/06/20 |
ASX - By Stock
|
37
|
13K
|
21
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
herro
|
18K |
7.1M |
16 |
27/04/20 |
27/04/20 |
ASX - By Stock
|
18K
|
7.1M
|
16
|
|
Sport
|
|
Re:
AFL Lastman Standing - Rnd 1
|
|
herro
|
93 |
30K |
1 |
21/03/19 |
21/03/19 |
Sport
|
93
|
30K
|
1
|
|
ASX - By Stock
|
ELE |
Re:
NSL v Coal Hub
|
|
herro
|
31 |
15K |
17 |
08/02/18 |
08/02/18 |
ASX - By Stock
|
31
|
15K
|
17
|
|
ASX - By Stock
|
ELE |
Re:
Ann: Additional 20,000t Purchase Order Received From IFO
|
|
herro
|
101 |
50K |
23 |
13/06/17 |
13/06/17 |
ASX - By Stock
|
101
|
50K
|
23
|
|
ASX - By Stock
|
ELE |
Re:
Ann: Trading Halt
|
|
herro
|
236 |
82K |
8 |
13/02/17 |
13/02/17 |
ASX - By Stock
|
236
|
82K
|
8
|
|
ASX - By Stock
|
ELE |
Re:
Ann: Steel Plant JV Progress Update
|
|
herro
|
63 |
24K |
27 |
23/12/16 |
23/12/16 |
ASX - By Stock
|
63
|
24K
|
27
|
|